Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-17-030569
Filing Date
2017-06-01
Accepted
2017-06-01 14:26:18
Documents
1
Effectiveness Date
2017-06-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10842
  Complete submission text file 0001144204-17-030569.txt   12200
Mailing Address 35 BRAINTREE HILL OFFICE PARK SUITE 304 BRAINTREE MA 02184
Business Address 35 BRAINTREE HILL OFFICE PARK SUITE 304 BRAINTREE MA 02184 215-630-7651
Euthymics Bioscience, Inc. (Filer) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-287854 | Film No.: 17884346
SIC: 2834 Pharmaceutical Preparations